UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Leukemia-associated antigens and their relevance to the immunotherapy of acute myeloid leukemia

Leukemia, 2012-10, Vol.26 (10), p.2186-2196

2012

Volltextzugriff (PDF)

An unusual presentation of gallstone disease

QJM : An International Journal of Medicine, 2011-06, Vol.104 (6), p.543-544

ANGUILLE, S

2011

Volltextzugriff (PDF)

Reduced humoral immune response after BNT162b2 coronavirus disease 2019 messenger RNA vaccination in cancer patients under antineoplastic treatment

ESMO open, 2021-10, Vol.6 (5), p.100274-100274, Article 100274

2021

Volltextzugriff (PDF)

PB2348: THE PATIENT'S PERSPECTIVE ON CLNICAL TRIALS: RESULTS FROM A REGIONAL SURVEY IN HAEMATOLOGICAL CENTERS IN ANTWERP

HemaSphere, 2022-06, Vol.6 (Suppl), p.2217-2218

2022

Volltextzugriff (PDF)

Interferon-α in acute myeloid leukemia: an old drug revisited

Leukemia, 2011-05, Vol.25 (5), p.739-748

2011

Volltextzugriff (PDF)

Comparison of S1 antibody titers between BNT162b2 and ChAdOx1 COVID-19 vaccination in cancer patients

ESMO open, 2022-04, Vol.7 (2), p.100414-100414, Article 100414

2022

Volltextzugriff (PDF)

P30 SINGLE COHORT RESULTS FROM MAJESTEC‐2: TECLISTAMAB (TEC) IN COMBINATION WITH SUBCUTANEOUS DARATUMUMAB (DARA) AND LENALIDOMIDE (LEN) IN PATIENTS WITH MULTIPLE MYELOMA (MM)

HemaSphere, 2023-05, Vol.7 (S2), p.27-27

2023

Volltextzugriff (PDF)

Vaccination of cancer patients with dendritic cells electroporated with mRNA encoding the wilms' tumor 1 protein (WT1): correlation of clinical effect and overall survival with T-cell response

Cytotherapy (Oxford, England), 2019-05, Vol.21 (5), p.S10-S10

2019

Volltextzugriff (PDF)

B09 CARTITUDE‐2 COHORT B 18‐MONTH FOLLOW‐UP: CILTACABTAGENE AUTOLEUCEL (CILTA‐CEL), A BCMA‐DIRECTED CAR‐T CELL THERAPY, IN PATIENTS WITH MULTIPLE MYELOMA (MM) AND EARLY RELAPSE AFTER INITIAL THERAPY

HemaSphere, 2023-05, Vol.7 (S2), p.8-8

2023

Volltextzugriff (PDF)

P12: TREATMENTS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: RETROSPECTIVE CHART REVIEW OF REAL‐WORLD OUTCOMES FOR STANDARD OF CARE

HemaSphere, 2022-04, Vol.6 (Suppl), p.17-18

2022

Volltextzugriff (PDF)

Identification of a Wilms' tumor 1-derived immunogenic CD4(+) T-cell epitope that is recognized in the context of common Caucasian HLA-DR haplotypes

Leukemia, 2013-03, Vol.27 (3), p.748-750

2013

Volltextzugriff (PDF)

S185: CARTITUDE‐2 COHORT B: UPDATED CLINICAL DATA AND BIOLOGICAL CORRELATIVE ANALYSES OF CILTACABTAGENE AUTOLEUCEL IN PATIENTS WITH MULTIPLE MYELOMA AND EARLY RELAPSE AFTER INITIAL THERAPY

HemaSphere, 2022-06, Vol.6, p.86-87

2022

Volltextzugriff (PDF)

B07: SAFETY AND EFFICACY OF CILTACABTAGENE AUTOLEUCEL, A CHIMERIC ANTIGEN RECEPTOR T‐CELL THERAPY DIRECTED AGAINST B‐CELL MATURATION ANTIGEN IN PATIENTS WITH MULTIPLE MYELOMA AND EARLY RELAPSE AFTER INITIAL THERAPY: CARTITUDE‐2 RESULTS

HemaSphere, 2022-04, Vol.6 (Suppl), p.9-10

2022

Volltextzugriff (PDF)

mRNA loading of human blood dendritic cells for anti-cancer vaccination

Cytotherapy (Oxford, England), 2013-04, Vol.15 (4), p.S35-S35

2013

Volltextzugriff (PDF)

Medical costs of treatment and survival of patients with acute myeloid leukemia in Belgium

Leukemia research, 2016-07, Vol.46, p.26-29

2016

Volltextzugriff (PDF)

mRNA Loaded CMRF-56 Blood Dendritic Cells Augment Anti-Cancer Immune Responses in Conjunction with Nivolumab

Cytotherapy (Oxford, England), 2016-06, Vol.18 (6), p.S100-S100

2016

Volltextzugriff (PDF)

Vaccination with Wilms' Tumor Antigen ( WT1) mRNA-Electroporated Dendritic Cells as an Adjuvant Treatment in 60 Cancer Patients: Report of Clinical Effects and Increased Survival in Acute Myeloid Leukemia, Metastatic Breast Cancer, Glioblastoma and Mesothelioma

Cytotherapy (Oxford, England), 2016-06, Vol.18 (6), p.S13-S14

2016

Volltextzugriff (PDF)

Anti-cancer vaccination using mRNA-loaded CMRF-56 immunoselected blood dendritic cells

Cytotherapy (Oxford, England), 2014-04, Vol.16 (4), p.S24-S24

2014

Volltextzugriff (PDF)

Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma

The New England journal of medicine, 2023-07, Vol.389 (4), p.335-347

2023

Volltextzugriff (PDF)

Generation of killer dendritic cells starting from blood monocytes using interleukin-15: prospects for the use in immunotherapy

Cytotherapy (Oxford, England), 2013-04, Vol.15 (4), p.S34-S34

2013

Volltextzugriff (PDF)

Functional study on TRPV1‐mediated signalling in the mouse small intestine: involvement of tachykinin receptors

Neurogastroenterology and motility, 2008-05, Vol.20 (5), p.546-556

2008

Volltextzugriff (PDF)

Recurrence after ROLL lumpectomy for invasive breast cancer

Breast (Edinburgh), 2008-12, Vol.17 (6), p.637-639

2008

Volltextzugriff (PDF)

mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients

AIDS (London), 2012-02, Vol.26 (4), p.F1-F12

2012

Volltextzugriff (PDF)

1666P Lower virus neutralizing titers against SARS-CoV-2 Omicron strain after third dose BNT162b2 following primo-vaccination with ChAdOx1 versus BNT162b2 in cancer patients

Annals of oncology, 2022-09, Vol.33, p.S1305-S1305

2022

Volltextzugriff (PDF)

Dendritic cell-based cancer gene therapy

Human gene therapy, 2009-10, Vol.20 (10), p.1106-1118

2009

Volltextzugriff (PDF)

1 – 25 von 206

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(194)
Mit Volltextzugriff
(185)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(19)
Plos One
(17)
Hemasphere
(10)
Cytotherapy
(9)
Clinical Lymphoma, Myeloma And Leukemia
(8)
Journal Of Clinical Oncology
(6)
Cancers
(5)
Transplantation And Cellular Therapy
(5)
Journal Of Cell Science
(4)
Leukemia
(4)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Leukemia-associated antigens and their relevance to the immunotherapy of acute myeloid leukemia

An unusual presentation of gallstone disease

Reduced humoral immune response after BNT162b2 coronavirus disease 2019 messenger RNA vaccination in cancer patients under antineoplastic treatment

PB2348: THE PATIENT'S PERSPECTIVE ON CLNICAL TRIALS: RESULTS FROM A REGIONAL SURVEY IN HAEMATOLOGICAL CENTERS IN ANTWERP

Interferon-α in acute myeloid leukemia: an old drug revisited

Comparison of S1 antibody titers between BNT162b2 and ChAdOx1 COVID-19 vaccination in cancer patients

P30 SINGLE COHORT RESULTS FROM MAJESTEC‐2: TECLISTAMAB (TEC) IN COMBINATION WITH SUBCUTANEOUS DARATUMUMAB (DARA) AND LENALIDOMIDE (LEN) IN PATIENTS WITH MULTIPLE MYELOMA (MM)

Vaccination of cancer patients with dendritic cells electroporated with mRNA encoding the wilms' tumor 1 protein (WT1): correlation of clinical effect and overall survival with T-cell response

B09 CARTITUDE‐2 COHORT B 18‐MONTH FOLLOW‐UP: CILTACABTAGENE AUTOLEUCEL (CILTA‐CEL), A BCMA‐DIRECTED CAR‐T CELL THERAPY, IN PATIENTS WITH MULTIPLE MYELOMA (MM) AND EARLY RELAPSE AFTER INITIAL THERAPY

P12: TREATMENTS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: RETROSPECTIVE CHART REVIEW OF REAL‐WORLD OUTCOMES FOR STANDARD OF CARE

Identification of a Wilms' tumor 1-derived immunogenic CD4(+) T-cell epitope that is recognized in the context of common Caucasian HLA-DR haplotypes

S185: CARTITUDE‐2 COHORT B: UPDATED CLINICAL DATA AND BIOLOGICAL CORRELATIVE ANALYSES OF CILTACABTAGENE AUTOLEUCEL IN PATIENTS WITH MULTIPLE MYELOMA AND EARLY RELAPSE AFTER INITIAL THERAPY

B07: SAFETY AND EFFICACY OF CILTACABTAGENE AUTOLEUCEL, A CHIMERIC ANTIGEN RECEPTOR T‐CELL THERAPY DIRECTED AGAINST B‐CELL MATURATION ANTIGEN IN PATIENTS WITH MULTIPLE MYELOMA AND EARLY RELAPSE AFTER INITIAL THERAPY: CARTITUDE‐2 RESULTS

mRNA loading of human blood dendritic cells for anti-cancer vaccination

Medical costs of treatment and survival of patients with acute myeloid leukemia in Belgium

mRNA Loaded CMRF-56 Blood Dendritic Cells Augment Anti-Cancer Immune Responses in Conjunction with Nivolumab

Vaccination with Wilms' Tumor Antigen ( WT1) mRNA-Electroporated Dendritic Cells as an Adjuvant Treatment in 60 Cancer Patients: Report of Clinical Effects and Increased Survival in Acute Myeloid Leukemia, Metastatic Breast Cancer, Glioblastoma and Mesothelioma

Anti-cancer vaccination using mRNA-loaded CMRF-56 immunoselected blood dendritic cells

Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma

Generation of killer dendritic cells starting from blood monocytes using interleukin-15: prospects for the use in immunotherapy

Functional study on TRPV1‐mediated signalling in the mouse small intestine: involvement of tachykinin receptors

Recurrence after ROLL lumpectomy for invasive breast cancer

mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients

1666P Lower virus neutralizing titers against SARS-CoV-2 Omicron strain after third dose BNT162b2 following primo-vaccination with ChAdOx1 versus BNT162b2 in cancer patients

Dendritic cell-based cancer gene therapy

Suchergebnisse filtern